How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko

How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko

From Pharma Sessions by Jonathan Kaskey

February 26, 2026 · 26 min · Episode 19

About this episode

This episode discusses the importance of launch readiness in the pharmaceutical industry with insights from Ana Bozas.

Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

People in this episode

Host: Jonathan Kaskey

Guest: Ana Bozas

Topics covered

  • drug launches
  • clinical evidence
  • pharmaceutical industry
  • launch readiness
  • medical strategy

Keywords

  • drug launches
  • clinical evidence
  • pharmaceutical
  • launch readiness
  • medical strategy

Mentioned in this episode

Organizations: Vera Therapeutics

More episodes of Pharma Sessions

Explore listener stats, chart rankings, contacts and more on the Pharma Sessions podcast page.